EMA/CO for high-risk gestational trophoblastic neoplasia: Good outcomes with induction low-dose etoposide-cisplatin and genetic analysis

Journal of Clinical Oncology

Volumn 31, Issue 2, 2013, Pages 280-286

  Alifrangis, Constantine ^a   Agarwal, Roshan ^a   Short, Delia ^a   Fisher, Rosemary A ^a   Sebire, Neil J ^a   Harvey, Richard ^a   Savage, Philip M ^a   Seckl, Michael J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; VINCRISTINE;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG FATALITY; FEMALE; FOLLOW UP; GENETIC ANALYSIS; HIGH RISK PATIENT; HUMAN; INDUCTION CHEMOTHERAPY; LIVER METASTASIS; LOW DRUG DOSE; LUNG METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SURVIVAL RATE; TREATMENT OUTCOME; TROPHOBLASTIC TUMOR;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COHORT STUDIES; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FEMALE; GESTATIONAL TROPHOBLASTIC DISEASE; HUMANS; METHOTREXATE; PREGNANCY; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 84872448260     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.1817     Document Type: Article

References (18)

1. Szulman AE, Surti U: The syndromes of hydatidiform mole: I. Cytogenetic and morphologic correlations. Am J Obstet Gynecol 131:665-671, 1978 (Pubitemid 8364343)
2. Feltmate CM, Genest DR, Goldstein DP, et al: Advances in the understanding of placental site trophoblastic tumor. J Reprod Med 47:337-341, 2002 (Pubitemid 34553231)
3. Shih IM, Kurman RJ: Epithelioid trophoblastic tumor: A neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol 22:1393-1403, 1998 (Pubitemid 28499130)
4. Sebire NJ, Lindsay I: Current issues in the histopathology of gestational trophoblastic tumors. Fetal Pediatr Pathol 29:30-44, 2010
5. Kajii T, Ohama K: Androgenetic origin of hydatidiform mole. Nature 268:633-634, 1977 (Pubitemid 8227851)
6. Seckl MJ, Sebire NJ, Berkowitz RS: Gestational trophoblastic disease. Lancet 376:717-729, 2010
7. Sebire NJ, Seckl MJ: Gestational trophoblastic disease: Current management of hydatidiform mole. BMJ 337:a1193, 2008
8. McNeish IA, Strickland S, Holden L, et al: Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 20:1838-1844, 2002 (Pubitemid 34273274)
9. Bower M, Newlands ES, Holden L, et al: EMA/CO for high-risk gestational trophoblastic tumors: Results from a cohort of 272 patients. J Clin Oncol 15:2636-2643, 1997 (Pubitemid 27289895)
10. Hancock BW, Welch EM, Gillespie AM, et al: A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease. Int J Gynecol Cancer 10:318-322, 2000
11. Fisher RA, Savage PM, MacDermott C, et al: The impact of molecular genetic diagnosis on the management of women with hCG-producing malignancies. Gynecol Oncol 107:413-419, 2007 (Pubitemid 350160849)
12. Mitchell H, Bagshawe KD, Newlands ES, et al: Importance of accurate human chorionic gonadotropin measurement in the treatment of gestational trophoblast disease and testicular cancer. J Reprod Med 51:868-870, 2006 (Pubitemid 44788832)
13. Harvey RA, Mitchell HD, Stenman UH, et al: Differences in total human chorionic gonadotropin immunoassay analytical specificity and ability to measure human chorionic gonadotropin in gestational trophoblastic disease and germ cell tumors. J Reprod Med 55:285-295, 2010
14. Newlands ES, Mulholland PJ, Holden L, et al: Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 18:854-859, 2000 (Pubitemid 30106617)
15. Wang J, Short D, Sebire NJ, et al: Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE). Ann Oncol 19:1578-1583, 2008
16. El-Helw LM, Seckl MJ, Haynes R, et al: Highdose chemotherapy and peripheral blood stem cell support in refractory gestational trophoblastic neoplasia. Br J Cancer 93:620-621, 2005 (Pubitemid 41486450)
17. Park SH, Park A, Kim JY, et al: A case of non-gestational choriocarcinoma arising in the ovary of a postmenopausal woman. J Gynecol Oncol 20:192-194, 2009
18. Fisher RA, Newlands ES, Jeffreys AJ, et al: Gestational and nongestational trophoblastic tumors distinguished by DNA analysis. Cancer 69:839-845, 1992